<DOC>
	<DOCNO>NCT01096407</DOCNO>
	<brief_summary>RATIONALE : Learning pain patient cancer receive paclitaxel may help plan treatment may help patient live comfortably . Studying sample urine patient cancer laboratory may help doctor identify learn biomarkers related muscle joint pain . PURPOSE : This phase I trial study role biomarkers muscle pain joint pain patient solid tumor receive paclitaxel .</brief_summary>
	<brief_title>Role Biomarkers Muscle Pain Joint Pain Patients With Solid Tumors Receiving Paclitaxel</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine change urinary prostaglandin E metabolite ( PGE-M ) level paclitaxel treatment patient variety solid tumor malignancy . - To determine whether change PGE-M level correlate paclitaxel dose . - To determine whether change urinary PGE-M level correlate patient report pain , measure visual analog scale Brief Pain Inventory short form ( BPI-SF ) . Secondary - To determine whether leukotriene level affect paclitaxel treatment . OUTLINE : At baseline ( prior first dose paclitaxel ) , patient complete questionnaire baseline pain symptom ( include Brief Pain Inventory short form visual analog scale ) ; cigarette smoking status second-hand smoke exposure ; routine use pain medication ( include NSAIDs , selective COX-2 inhibitor , opioid analgesic ) , corticosteroid , leukotriene antagonist ( montelukast zafirlukast ) . Patients also complete questionnaire pain daily day 2-7 paclitaxel administration . Urine sample collect baseline urinary prostaglandin E metabolite ( PGE-M ) , urinary leukotriene E_4 ( LTE_4 ) , urinary cotinine level day 4 urinary PGE-M LTE_4 level .</detailed_description>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Solid malignancy type Patients must schedule receive first dose paclitaxel VanderbiltIngram Cancer Center Any paclitaxelcontaining regimen dose schedule allow PATIENT CHARACTERISTICS : Not pregnant Accessible followup Able submit urine sample Able complete questionnaire PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>pain</keyword>
	<keyword>arthralgia</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>